DeepMed Research

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Establishing a Prognostic Model for Stroke Recovery

Not Applicable

Recruiting

Conditions: Stroke, Acute

Interventions: Device: trancranial magnetic stimulation

First Posted Date: 2022-04-18

Last Posted Date: 2024-08-16

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 68

Registration Number: NCT05332652

Locations: 🇸🇬
Alexandra Hospital, Singapore, Singapore
🇸🇬
National University Hospital, Singapore, Singapore

Multidisciplinary Rehabilitation Programme for Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: physiotherapy class

First Posted Date: 2022-04-01

Last Posted Date: 2022-11-02

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 70

Registration Number: NCT05306808

Locations: 🇸🇬
National Univerity Hospital, Singapore, Singapore

Phase II Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Phase 2

Not yet recruiting

Conditions: Nasopharyngeal Cancer

Interventions: Drug: induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
Drug: cisplatin and gemcitabine

First Posted Date: 2022-03-31

Last Posted Date: 2022-03-31

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 50

Registration Number: NCT05305131

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Phase 1

Active, not recruiting

Conditions: HER2-negative Breast Cancer
Advanced Solid Tumor

Interventions: Drug: ADG106
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: Paclitaxel

First Posted Date: 2022-03-11

Last Posted Date: 2024-05-17

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 66

Registration Number: NCT05275777

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Steroid Injection in De Quervain Tenosynovitis

Conditions: De Quervain Disease

First Posted Date: 2022-03-02

Last Posted Date: 2022-03-02

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 50

Registration Number: NCT05261737

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC

Phase 1

Conditions: Metastatic Non Small Cell Lung Cancer

Interventions: Drug: Nivolumab
Drug: ADG106

First Posted Date: 2022-02-11

Last Posted Date: 2022-03-25

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 53

Registration Number: NCT05236608

Locations: 🇸🇬
National Cancer Centre Singapore, Singapore, Singapore
🇸🇬
National University Hospital, Singapore, Singapore

MLCT Oil for Fatty Liver - PASS Trial

Not Applicable

Conditions: Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Steatohepatitis
NAFLD

Interventions: Dietary Supplement: LCT Oil (Corn Oil)
Dietary Supplement: MLCT Oil

First Posted Date: 2022-02-01

Last Posted Date: 2022-02-25

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 30

Registration Number: NCT05217745

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Study of Virtual Simulated Resuscitation in Junior Clinicians

Not Applicable

Completed

Conditions: Education, Medical

Interventions: Other: Team based in situ simulation
Other: Virtual simulation

First Posted Date: 2022-01-21

Last Posted Date: 2023-03-03

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 40

Registration Number: NCT05201950

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Effect of Obstetric Anesthesia and Delivery Mode On Neurodevelopmental And Behavioural Outcomes In A Population-Based Birth Cohort

Completed

Conditions: Behavior
Neurodevelopmental Disorders

Interventions: Other: Behavioural questionnaires and assessments on mother and child

First Posted Date: 2022-01-19

Last Posted Date: 2023-07-27

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 1176

Registration Number: NCT05196750

Locations: 🇸🇬
KKH Women and Children Hospital, Singapore, Singapore
🇸🇬
National University Hospital, Singapore, Singapore

Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Lenvatinib + Letrozole
Drug: Fulvestrant

First Posted Date: 2022-01-06

Last Posted Date: 2024-05-17

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 120

Registration Number: NCT05181033

Locations: 🇸🇬
Nationa University Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy